Diabetic Neuropathy, Painful Terminated Phase 2 Trials for Perzinfotel (DB12365)

IndicationStatusPhase
DBCOND0030279 (Diabetic Neuropathy, Painful)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00073034Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic NeuropathyTreatment